This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|June 2, 2020
- Pharmaceutical Technology-06-02-2020
- Volume 44
- Issue 6
Speed Roll-Up Door for Cleanrooms
Rite-Hite’s LiteSpeed Clean high-speed door is a speed roll-up door designed to provide cleanrooms with good manufacturing practice (GMP) and FDA-compliant integrity, reliability, and safety.
Rite-Hite’s LiteSpeed Clean high-speed door is a speed roll-up door designed to provide cleanrooms with good manufacturing practice (GMP) and FDA-compliant integrity, reliability, and safety.
The PVC vinyl door uses non-exposed fasteners to resist dust, while its roll-up design promotes a peak operating speed of 65” per second and a smaller physical footprint. Because of its tight seal, it can support room-to-room pressure differentials of up to 0.2 InWC.
Safety features include the TRUE Auto Re-feed, which automatically reconfigures the door back on its tracks if it is bumped or impacted; soft break-away technology for additional protection for product, personnel, and equipment; an optional full-width vision panel; and a reversing slack sensor to reverse the door’s course.
Articles in this issue
over 6 years ago
What’s Next in Air Transportation for Clinical Trial Logisticsover 6 years ago
2019 Investments Centered around Cell and Gene Therapiesover 6 years ago
Generic Drugs in Spotlight as Pandemic Creates Shortagesover 6 years ago
Are We All In This Together?over 6 years ago
Following Guidelines During a Crisisover 6 years ago
Intelligent Packaging Promotes Interaction with Patientsover 6 years ago
Why Do Disinfectant Residues Matter?over 6 years ago
Formulating for Convenience and Complianceover 6 years ago
Reducing Risk with Abuse‑Deterrent Formulationsover 6 years ago
Better Connected: The Value of Connected Drug DeliveryRelated to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.